Mucous Membrane Decontamination Market - Top Companies and Manufacturers

  • Report ID: 4189
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Companies Dominating the Mucous Membrane Decontamination Landscape

    • Astellas Pharma Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Bausch Health Companies Inc.
    • Genentech, Inc.
    • Lipidor AB
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Sun Pharmaceutical Industries Limited
    • EPI Health, LLC
    • Mölnlycke Health Care AB
    • Reckitt Benckiser Group plc

Browse Key Market Insights with Data Illustration:

In the News

  • Astellas Pharma Inc. announced its global strategic collaboration with Sutro Biopharma, Inc. along with licensing agreement to improvise the development procedure of novel immunostimulatory antibody-drug conjugates shortly known as iADCs.

  • Sun Pharmaceutical Industries Limited and its entirely owned subsidiaries launched an oral drug, Bempedoic Acid, under the brand name Brillo in India which focuses on low-density lipoprotein cholesterol to be decreased.


Author Credits:  Radhika Pawar


  • Report ID: 4189
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of mucous membrane decontamination is evaluated at USD 9.2 Billion.

The mucous membrane decontamination market size was over USD 8.08 Billion in 2023 and is anticipated to exceed USD 52 Billion by the end of 2036, growing at over 15.4% CAGR during the forecast period i.e., between 2024-2036. Increasing inclination of global population toward personal hygiene and higher prevalence of post-surgical wound infection are the major factors driving the market growth.

North America is poised to account for majority industry share by 2036, attributed to higher prevalence of autoimmune diseases driven by presence of a developed healthcare infrastructure and growing inclination of people and clinicians toward the utilization of novel drugs.

Astellas Pharma Inc., Bausch Health Companies Inc., Genentech, Inc., Lipidor AB, Pfizer Inc., Merck & Co., Inc., Sun Pharmaceutical Industries Limited, EPI Health, LLC, Mölnlycke Health Care AB, Reckitt Benckiser Group plc
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample